Alaunos Therapeutics (TCRT) Treasury Shares (2009 - 2023)

Alaunos Therapeutics has reported Treasury Shares for 15 years, with the latest figure at $437500.0 in Q3 2023.

• For the quarter ending Q3 2023, Treasury Shares rose 2233.33% year-over-year to $437500.0; the trailing twelve-month figure through Sep 2023 stood at $437500.0 (up 2233.33% YoY), and the FY2022 full-year result was $62604.0, down 21.65% from the prior year.
• Treasury Shares for Q3 2023 stood at $437500.0, down from $657187.0 in the prior quarter.
• The five-year high for Treasury Shares was $1.6 million in Q3 2019, with the low at $18750.0 in Q3 2022.
• Historically, Treasury Shares has averaged $828850.3 across 5 years, with a median of $939636.0 in 2019.
• Annual changes were most pronounced in 2022 — Treasury Shares tumbled 98.76% — and 2023, when it jumped 2233.33%.
• Alaunos Therapeutics' Treasury Shares stood at $939636.0 in 2019, then retreated by 16.32% to $786280.0 in 2020, then sank by 89.84% to $79905.0 in 2021, then decreased by 21.65% to $62604.0 in 2022, then jumped by 598.84% to $437500.0 in 2023.
• The last three Treasury Shares figures came in at $437500.0 (Q3 2023), $657187.0 (Q2 2023), and $898125.0 (Q1 2023), per Business Quant data.